Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/11723014

Circulation 2001 Nov 27 104 22 2653-9

Download in:

View as

General Info

PMID
11723014